Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing

Vaccine. 2016 Aug 31;34(38):4468. doi: 10.1016/j.vaccine.2016.05.029.

Authors

Jeanne E Hendrickson¹, Christopher A Tormey²

Affiliations

¹ Yale University School of Medicine, Department of Laboratory Medicine, New Haven, CT, United States; Yale University School of Medicine, Department of Pediatrics, New Haven, CT, United States. Electronic address: jeanne.hendrickson@yale.edu.
² Yale University School of Medicine, Department of Laboratory Medicine, New Haven, CT, United States; VA CT Healthcare System, Pathology and Laboratory Medicine Service, West Haven, CT, United States.

PMID: 27553747
DOI: 10.1016/j.vaccine.2016.05.029

No abstract available

Keywords: Autoimmunity; Complex regional pain syndrome; Dysautonomia; HPV; Human papilloma virus vaccination.

Publication types

Letter
Comment

MeSH terms

Autoantibodies*
Histocompatibility Testing
Humans
Papillomaviridae
Papillomavirus Infections
Papillomavirus Vaccines
Primary Dysautonomias
Uterine Cervical Neoplasms
Vaccination*

Substances

Autoantibodies
Papillomavirus Vaccines